SXTC | China SXT Pharmaceuticals, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.4651 - 0.5381
52 Week Range	0.4651 - 6.39
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	325,953
Average Volume	621,548
Shares Outstanding	3,476,090
Market Cap	1,664,700
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2019-01-04

Valuation
Profitability
Growth
Health
P/E Ratio	-0.13
Forward P/E Ratio	N/A
EPS	-3.57
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	75
Country	China
Website	SXTC

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.

SXTC's peers: AKAN, AYTU, BFRI, CPHI, YCBD, COSM, PTPI, RDHL, RMTI, SBFM, SIGA, SNOA, GSAC, SHPH, QLI, PRFX, RGC, PROC, JUPW, HUGE, ACOR, LSDI, SGIOY, ALIM, GHSI, HCANF

*Chart delayed

Analyzing fundamentals for SXTC we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see SXTC Fundamentals page.

Watching at SXTC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on SXTC Technicals page.